3D-Culture System for Heart Regeneration and Cardiac Medicine
暂无分享,去创建一个
[1] D. Torella,et al. Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.
[2] N. Kawaguchi. Stem cells for cardiac regeneration and possible roles of the transforming growth factor-β superfamily , 2012, Biomolecular concepts.
[3] Y. Furutani,et al. Prospective In Vitro Models of Channelopathies and Cardiomyopathies , 2012, Stem cells international.
[4] Nikolay Bazhanov,et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.
[5] Jeffrey H. Omens,et al. Increased Infarct Wall Thickness by a Bio-Inert Material Is Insufficient to Prevent Negative Left Ventricular Remodeling after Myocardial Infarction , 2011, PloS one.
[6] E. Braunwald. Congestive heart failure: a half century perspective , 2001 .
[7] T. Nakanishi,et al. Cell Shape and Cardiosphere Differentiation: A Revelation by Proteomic Profiling , 2013, Biochemistry research international.
[8] Danielle Rockwood,et al. Three-dimensional culture alters primary cardiac cell phenotype. , 2010, Tissue engineering. Part A.
[9] Shunichi Homma,et al. Composite scaffold provides a cell delivery platform for cardiovascular repair , 2011, Proceedings of the National Academy of Sciences.
[10] N. Kawaguchi. Adult cardiac-derived stem cells: differentiation and survival regulators. , 2011, Vitamins and hormones.
[11] Tong Hao,et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. , 2009, Tissue engineering. Part A.
[12] Jürgen Hescheler,et al. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar , 2010, BMC Developmental Biology.
[13] Jennifer M. Singelyn,et al. Injectable Materials for the Treatment of Myocardial Infarction and Heart Failure: The Promise of Decellularized Matrices , 2010, Journal of cardiovascular translational research.
[14] P. Stayton,et al. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. , 2011, Biomaterials.
[15] Jennifer M. Singelyn,et al. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. , 2009, Biomaterials.
[16] E. Braunwald,et al. Congestive Heart Failure: Fifty Years of Progress , 2000, Circulation.
[17] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[18] Sean P. Palecek,et al. Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.
[19] Masayuki Yamato,et al. Concise Review: Cell Therapy and Tissue Engineering for Cardiovascular Disease , 2012, Stem cells translational medicine.
[20] T. Okano,et al. Cell sheet engineering for myocardial tissue reconstruction. , 2003, Biomaterials.
[21] Peter W Zandstra,et al. Creation of mouse embryonic stem cell-derived cardiac cell sheets. , 2011, Biomaterials.
[22] S. Yamanaka,et al. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. , 2010, Cardiovascular research.
[23] T. Okano,et al. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). , 1993, Journal of biomedical materials research.
[24] A Ratcliffe,et al. Scaffold-Based Three-Dimensional Human Fibroblast Culture Provides a Structural Matrix That Supports Angiogenesis in Infarcted Heart Tissue , 2001, Circulation.
[25] P. Bourgine,et al. Tissue decellularization by activation of programmed cell death. , 2013, Biomaterials.
[26] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[27] Gordon Keller,et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells , 2011, Nature Biotechnology.
[28] Rumiko Matsuoka,et al. Micro and nano-scale in vitro 3D culture system for cardiac stem cells. , 2010, Journal of biomedical materials research. Part A.
[29] A. DeMaria,et al. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. , 2012, Journal of the American College of Cardiology.
[30] T. Okano,et al. Thermo‐responsive polymeric surfaces; control of attachment and detachment of cultured cells , 1990 .
[31] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[32] R. Matsuoka,et al. Characterization of long-term cultured c-kit+ cardiac stem cells derived from adult rat hearts. , 2010, Stem cells and development.
[33] E. Sasaki,et al. Nongenetic method for purifying stem cell–derived cardiomyocytes , 2010, Nature Methods.
[34] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[35] D. Malan,et al. Cardiomyocytes Obtained From Induced Pluripotent Stem Cells With Long-QT Syndrome 3 Recapitulate Typical Disease-Specific Features In Vitro , 2011, Circulation research.
[36] Doris A Taylor,et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.
[37] R. Matsuoka,et al. Myogenic differentiation in atrium‐derived adult cardiac pluripotent cells and the transcriptional regulation of GATA4 and myogenin on ANP promoter , 2010, Genes to cells : devoted to molecular & cellular mechanisms.
[38] Marius Wernig,et al. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] M. Pfeffer,et al. Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. , 1991, The American journal of cardiology.
[40] Milica Radisic,et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Khademhosseini,et al. Microscale technologies for tissue engineering and biology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[42] R. Matsuoka,et al. TGF-beta superfamily regulates a switch that mediates differentiation either into adipocytes or myocytes in left atrium derived pluripotent cells (LA-PCS). , 2010, Biochemical and biophysical research communications.
[43] Ngan F Huang,et al. Injectable biopolymers enhance angiogenesis after myocardial infarction. , 2005, Tissue engineering.
[44] Richard T. Lee,et al. Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells , 2005, Circulation.
[45] Lior Gepstein,et al. Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.
[46] S. Yuasa,et al. Induced Pluripotent Stem Cells in Cardiovascular Medicine , 2011, Stem cells international.
[47] R. Matsuoka,et al. Proteomic comparison of spherical aggregates and adherent cells of cardiac stem cells. , 2011, International journal of cardiology.
[48] R. Matsuoka,et al. c-kitpos GATA-4 High Rat Cardiac Stem Cells Foster Adult Cardiomyocyte Survival through IGF-1 Paracrine Signalling , 2010, PloS one.
[49] Masayuki Yamato,et al. Regenerative Therapies Using Cell Sheet-Based Tissue Engineering for Cardiac Disease , 2011, Cardiology research and practice.
[50] S. Shroff,et al. Engineered early embryonic cardiac tissue retains proliferative and contractile properties of developing embryonic myocardium. , 2006, American journal of physiology. Heart and circulatory physiology.
[51] J. Yamashita. ES and iPS cell research for cardiovascular regeneration. , 2010, Experimental cell research.
[52] Harald C Ott,et al. Organ engineering based on decellularized matrix scaffolds. , 2011, Trends in molecular medicine.